Cases & Deals

Biolase Technology conducts inter partes reexamination of U.S. Patent No. 7,485,116

Clients Biolase Technology Inc.

Jones Day represents Biolase Technology Inc. in an inter partes reexamination of U.S. Patent No. 7,485,116.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.